Temodar
information and resources from the National Cancer Institute
temozolomide
Accel. Approv. (clinical benefit not established) Treatment of adult patients with refractory anaplastic astrocytoma, i.e., patients at first relapse with disease progression on a nitrosourea and procarbazine containing regimen
Schering Aug 11 1999
|
|
|
|
news articles
Temodar® and Thalomid® Effective for Advanced Neuroendocrine ... Mar 20, 2006
Cancer Consultants (press release), According to an article recently published in the Journal of Clinical Oncology, the treatment combination consisting of Temodar® (temozolomide) and Thalomid ...
Temodar® and Thalomid® Effective for Metastatic Neuroendocrine ... Mar 21, 2006
Cancer Consultants (press release), Researchers from the Dana-Farber Cancer Center have reported that the oral administration of Temodar (temozolomide) and Thalomid (thalidomide) in patients with ...
Brain Surgeon Becomes Brain Cancer Patient Mar 6, 2006
CancerWise His colleagues presented him two treatment options: standard treatment [radiation and chemotherapy called Temodar® (temozolomide)], or radiation followed by ...
Schering-Plough debt rating outlook raised to stable - S&P Mar 24, 2006
Forbes However, the company does not have any major patent expirations over the next several years, with cancer product Temodar in 2011 being the earliest. ...
Addition of Temodar® Does Not Reduce Quality of Life in ... Nov 21, 2005
Cancer Consultants (press release), According to a recent article published in an early online edition of The Lancet Oncology, the addition of the chemotherapy agent Temodar (temozolomide) to ...
Gleevec® plus Hydroxyurea Beneficial for Some Patients with ... Dec 20, 2005
Cancer Consultants (press release), ...the trial. They had had received prior treatment with radiation therapy and Temodar® (temozolomide)-based chemotherapy. The following ...
Top cancer drugs out of reach Dec 7, 2005
New Zealand Herald, Herceptin, hailed as a potential cure for breast cancer, costs $60,000 to $120,000 a patient a year and the brain cancer drug Temodar costs $50,000 or more. ...
Wall Street Journal Examines How Drug Companies Can Profit From ... Dec 1, 2005
Kaiser network.org, For instance, PSI covered 50% of a copayment for a six-week course Temodar, a Schering-Plough treatment that costs $1,272 per week, for a New Jersey woman with ...
Schering-Plough uses OMS Technology in new deal Nov 18, 2005
BiopharmaReporter.com, The clinical benefit of Temodar is well established for the treatment of certain types of brain tumours. However the pharmacogenomics ...
Through charities, drug makers help people Dec 1, 2005
Pittsburgh Post Gazette, She was prescribed a new drug to be taken in combination with radiation. The retail price of a one-week supply of the pill, called Temodar, is $1,272. ...
|
|
